查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553506

生物活性創傷護理市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030 年

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

生物活性創傷護理市場的成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，全球生物活性創傷護理市場預計將達到184億美元，2024年至2030年複合年成長率為7.4%。

壓力性潰瘍、糖尿病足和其他皮膚相關感染疾病等慢性皮膚病的盛行率正在增加。生物活性創傷護理產品提供了有效治療上述病症的有效治療方法。

因此，隨著目標人口的增加，生物活性創傷護理市場預計將出現利潤豐厚的成長。患者個人衛生意識的提高正在增加對這些產品的需求。意識層級的提高鼓勵患者儘早尋求醫療建議，以便及時介入。

近年來，人均醫療保健支出增加，可支配收入增加，使公民可以在醫療保健設施上花費更多，從而促進市場成長。先進產品的開發，例如含有多種成分的組合傷口敷料，可為患者提供多種好處，預計將推動對這些產品的需求。

生物活性創傷護理市場報告亮點

  • 濕性創傷護理佔市場主導地位，2023年佔61.1%的佔有率。濕潤的傷口敷料可保持適當的濕度，防止脫水，促進細胞遷移，創造最佳的癒合環境並加速傷口縫合。
  • 2023 年，一般外科佔據最大的市場收益佔有率，達到 68.6%。普通外科領域進一步分為整形外科、皮膚科、小兒科和其他應用。
  • 北美生物活性創傷護理市場主導全球生物活性創傷護理市場，2023年收益佔有率為42.6%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章生物活性創傷護理市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生物活性創傷護理市場分析工具
    • 波特的分析
    • PESTEL分析

第4章生物活性創傷護理市場：產品評估與趨勢分析

  • 細分儀表板
  • 生物活性創傷護理市場：產品變化分析，百萬美元，2023-2030
  • 濕潤創傷護理
  • 抗菌創傷護理
  • 主動穿衣

第5章生物活性創傷護理市場：應用估算與趨勢分析

  • 細分儀表板
  • 生物活性創傷護理市場：應用變化分析，百萬美元，2023-2030
  • 一般外科
  • 微創手術

第6章生物活性創傷護理市場：區域估計和趨勢分析

  • 生物活性創傷護理市場佔有率（按地區），2023 年和 2030 年，百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • B. Braun SE
    • Essity Health &Medical
    • 3M
    • Convatec Group PLC
    • Covalon Technologies Ltd
    • DermaRite Industries LLC
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Monlnlycke Health Care AB
    • Smith+Nephew
簡介目錄
Product Code: GVR-1-68038-081-1

Bioactive Wound Care Market Growth & Trends:

The global bioactive wound care market is expected to reach USD 18.4 billion by 2030 and expanding at a CAGR of 7.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians' advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

Bioactive Wound Care Market Report Highlights:

  • Moist wound care dominated the market and accounted for a share of 61.1% in 2023. Moist wound dressings create an optimal healing environment by maintaining the right moisture level, preventing dehydration, and promoting cell migration for faster closure.
  • General surgery accounted for the largest market revenue share of 68.6% in 2023. The general surgery segment is further classified into plastic, dermatological, pediatric and others applications.
  • North America bioactive wound care market dominated the global bioactive wound care market with a revenue share of 42.6% in 2023, driven by the existence of a substantial number of individuals with diabetes and the quick acceptance of modern wound treatment methods.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioactive Wound Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Moist Wound Care
    • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Foam
        • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Alginate
        • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Film
        • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Hydrocolloid
        • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Hydrogel
        • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Antimicrobial Wound Care
    • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Silver Based
        • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Non-Silver Based
        • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Active Dressing
    • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Biomaterial
        • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. Skin Substituents
        • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 5.3. General Surgery
    • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.1. Plastic
        • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Dermatological
        • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.3. Pediatric
        • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
        • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Minimally Invasive Surgery
    • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

  • 6.1. Bioactive Wound Care Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Essity Health & Medical
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. 3M
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Convatec Group PLC
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Covalon Technologies Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. DermaRite Industries LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hollister Incorporated
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Integra LifeSciences Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Johnson & Johnson Services, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Medtronic
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Monlnlycke Health Care AB
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Smith+Nephew
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives